Trial Profile
Emergency room clinical trial of Diphenhydramine/trimethobenzamide in migraine patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2016
Price :
$35
*
At a glance
- Drugs Diphenhydramine/trimethobenzamide (Primary)
- Indications Migraine
- Focus Proof of concept; Therapeutic Use
- Sponsors Multi-Corp International
- 27 Jan 2016 New trial record
- 21 Jan 2016 According to MultiCorp media release, company has received a report from the U.S. Food and Drug Administration that gives the company specific guidelines in conducting this trial.